- Home
- LOB vs DYN Comparison
LOB vs DYN Comparison
Compare LOB & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOB
- DYN
- Stock Information
- Founded
- LOB 2008
- DYN 1984
- Country
- LOB United States
- DYN United States
- Employees
- LOB N/A
- DYN N/A
- Industry
- LOB Major Banks
- DYN Medicinal Chemicals and Botanical Products
- Sector
- LOB Finance
- DYN Health Care
- Exchange
- LOB Nasdaq
- DYN Nasdaq
- Market Cap
- LOB 1.7B
- DYN 1.9B
- IPO Year
- LOB 2015
- DYN 2020
- Fundamental
- Price
- LOB $31.37
- DYN $17.47
- Analyst Decision
- LOB Hold
- DYN Strong Buy
- Analyst Count
- LOB 3
- DYN 14
- Target Price
- LOB $40.00
- DYN $34.93
- AVG Volume (30 Days)
- LOB 278.0K
- DYN 2.9M
- Earning Date
- LOB 10-22-2025
- DYN 11-05-2025
- Dividend Yield
- LOB 0.39%
- DYN N/A
- EPS Growth
- LOB N/A
- DYN N/A
- EPS
- LOB 1.49
- DYN N/A
- Revenue
- LOB $434,209,000.00
- DYN N/A
- Revenue This Year
- LOB $44.86
- DYN N/A
- Revenue Next Year
- LOB $16.20
- DYN N/A
- P/E Ratio
- LOB $21.16
- DYN N/A
- Revenue Growth
- LOB 7.02
- DYN N/A
- 52 Week Low
- LOB $22.68
- DYN $6.36
- 52 Week High
- LOB $50.17
- DYN $35.68
- Technical
- Relative Strength Index (RSI)
- LOB 36.97
- DYN 48.46
- Support Level
- LOB $30.75
- DYN $23.05
- Resistance Level
- LOB $32.39
- DYN $24.25
- Average True Range (ATR)
- LOB 1.07
- DYN 1.43
- MACD
- LOB -0.17
- DYN -0.18
- Stochastic Oscillator
- LOB 16.88
- DYN 22.22
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.